PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

'Not just a flavoring:' Menthol and nicotine, combined, desensitize airway receptors

2014-11-16
(Press-News.org) WASHINGTON -- Menthol acts in combination with nicotine to desensitize receptors in lungs' airways that are responsible for nicotine's irritation, say neuroscientists at Georgetown University Medical Center (GUMC). "We know that a menthol cough drop soothes a scratchy, sore throat. The question we looked at is if and how it works when the irritant is nicotine," says a study author, Kenneth Kellar, PhD, a professor of pharmacology at GUMC. The findings, which represent work by Georgetown University investigators in GUMC's Department of Pharmacology & Physiology, will be presented by Hoai Ton, PhD, a post-doctoral researcher, on Sunday, Nov. 16 at Neuroscience 2014, the Society for Neuroscience's annual meeting in Washington. "This study supports the notion that menthol is not just a flavoring, but has a pharmacologic effect," Kellar says. The U.S. Food and Drug Administration (FDA) is considering restrictions on menthol cigarettes because it has determined that menthol in cigarettes is likely associated with increased initiation and progression to regular cigarette smoking, increased dependence, and reduced success in smoking cessation, especially among African American menthol smokers. But FDA's review of the available research and evidence relating to menthol cigarettes, issued in July 2013, also concluded, "From the available studies, the weight of evidence supports the conclusion that menthol in cigarettes is not associated with an increase in disease risk to the user compared to non-menthol cigarette smokers." At the same time, the use of menthol cigarettes is especially high among African-American smokers, and research has shown a higher rate of lung cancer in African American smokers compared to other smokers. "The issue may be that menthol in the presence of nicotine may reduce the irritation enough that a smoker can inhale more deeply, bringing not just nicotine but toxic smoke products farther into the lungs," says co-investigator Gerald Ahern, PhD, an associate professor of pharmacology at GUMC. 'While beyond the scope of this study, it is possible that such deeper inhalation of menthol cigarettes, to the extent it occurs, increases the already substantial health harms from smoking."

The researchers say their study provides a better understanding of how menthol affects the function of the α3β4 receptor, one of the most prevalent nicotinic acetylcholine receptors expressed in the peripheral nervous system. These receptors are expressed in airway sensory nerves as well as other neurons. "These receptors are also found in the brain, but we don't know yet what effect menthol has on those receptors, or whether they contribute, in any way, to nicotine addiction," Kellar says.

INFORMATION:

Study contributors also include research assistant Thao Olson. The research was funded by a National Institutes of Health grant (DA012976). The authors report having no personal financial interests related to the study.

About Georgetown University Medical Center Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.

Follow us: Twitter @GUMedCenter and Facebook https://www.facebook.com/GUMCUpdate.



ELSE PRESS RELEASES FROM THIS DATE:

High mortality associated with STEMI heart attacks that occur in hospitalized patients

High mortality associated with STEMI heart attacks that occur in hospitalized patients
2014-11-16
In 2013, University of North Carolina School of Medicine researchers published a study with a surprising finding: Patients who suffered an ST elevation myocardial infarction (STEMI) heart attack while in the hospital for something else are more likely to die than patients who had the same type of heart attack outside the hospital. Today the UNC researchers published a new study, based on data from more than 62,000 patients treated at hundreds of hospitals in California, which confirms their earlier finding. "This study is the largest ever performed on patients who ...

Risk of death may be higher if heart attack occurs in a hospital

2014-11-16
Prashant Kaul, M.D., of the University of North Carolina, Chapel Hill, and colleagues conducted a study to define the incidence and treatment and outcomes of patients who experience a certain type of heart attack during hospitalization for conditions other than acute coronary syndromes. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. Early restoration of blood flow with percutaneous coronary intervention (PCI; a procedure such as stent placement used to open narrowed coronary arteries) or administration of medication to dissolve ...

Overall death rate from heart disease declines, although increase seen for certain types

2014-11-16
Matthew D. Ritchey, D.P.T., of the Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues examined the contributions of heart disease subtypes to overall heart disease mortality trends during 2000-2010. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. Despite considerable information on overall heart disease (HD) and coronary HD (CHD) mortality trends, less is known about trends for other HD subtypes. The researchers analyzed mortality data from the CDC WONDER database, which contains death certificate information ...

Device's potential as alternative to warfarin for stroke prevention in patients with a-fib

2014-11-16
Vivek Y. Reddy, M.D., of the Icahn School of Medicine at Mount Sinai, New York, and colleagues examined the long-term efficacy and safety, compared to warfarin, of a device to achieve left atrial appendage closure in patients with atrial fibrillation. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. The left atrial appendage (LAA) is a pouch-like appendix located in the upper left chamber of the heart. Studies have suggested that the LAA is the major source of clots that block blood vessels in patients with atrial fibrillation ...

Use of beta-blockers for certain type of heart failure linked with improved survival

2014-11-16
Lars H. Lund, M.D., Ph.D., of the Karolinska Institutet, Stockholm, Sweden, and colleagues conducted a study to examine whether beta-blockers are associated with reduced mortality in heart failure patients with preserved ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction).The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. Up to half of patients with heart failure have normal or near-normal ejection fraction, termed heart failure with preserved ejection fraction (HFPEF). The risk of ...

Prevalence, risk of death of type of coronary artery disease in heart attack patients

2014-11-16
Duk-Woo Park, M.D., of the University of Ulsan College of Medicine, Seoul, Korea, and Manesh R. Patel, M.D., of the Duke Clinical Research Institute, Durham, N.C., and colleagues investigated the incidence, extent, and location of obstructive non-infarct-related artery (IRA) disease and compared 30-day mortality according to the presence of non-IRA disease in patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack). Obstructive non-IRA disease is blockage in arteries not believed to be the cause ...

Comparison of methods to achieve artery closure following coronary angiography

2014-11-16
Stefanie Schulz-Schupke, M.D., of the Deutsches Herzzentrum Munchen, Technische Universitat, Munich, Germany and colleagues assessed whether vascular closure devices are noninferior (not worse than) to manual compression in terms of access site-related vascular complications in patients undergoing diagnostic coronary angiography. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. Percutaneous (through the skin) coronary angiography and interventions have become a cornerstone in the diagnosis and treatment of coronary artery disease. ...

Follow-up testing indicated for inherited cardiac syndrome that can cause sudden death

2014-11-16
Giulio Conte, M.D., of the Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium and colleagues investigated the clinical significance of repeat testing after puberty in asymptomatic children with a family history of Brugada syndrome who had an initial negative test earlier in childhood. Brugada syndrome is a genetic disease that is characterized by abnormal electrocardiogram findings without structural heart disease and an increased risk of sudden cardiac death. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue. Brugada ...

Half of STEMI heart attack patients may have additional clogged arteries

2014-11-16
DURHAM, N.C. - A blocked artery causes a deadly kind of heart attack known as STEMI, and a rapid response to clear the blockage saves lives. But in more than half of cases studied recently by Duke Medicine researchers, one or both of the patient's other arteries were also obstructed, raising questions about whether and when additional procedures might be undertaken. In a study published in the Nov. 19, 2014, issue of the Journal of the American Medical Association, Duke researchers and their colleagues report the first large analysis of how often these secondary blockages ...

Beta blockers could benefit patients with HFPEF

Beta blockers could benefit patients with HFPEF
2014-11-16
A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks well-established treatment. HFPEF involves an impaired ability of the heart to fill with blood, and affects nearly 2% of the population. These new findings are being published in the scientific periodical JAMA. Heart failure was for a long time defined as reduced ability to contract the heart and pump oxygenated blood out to the rest of the body. This condition is often ...

LAST 30 PRESS RELEASES:

Fecal microbiome and bile acid profiles differ in preterm infants with parenteral nutrition-associated cholestasis

The Institute of Science and Technology Austria (ISTA) receives €5 million donation for AI research

Study finds link between colorblindness and death from bladder cancer

Tailored treatment approach shows promise for reducing suicide and self-harm risk in teens and young adults

Call for papers: AI in biochar research for sustainable land ecosystems

Methane eating microbes turn a powerful greenhouse gas into green plastics, feed, and fuel

Hidden nitrogen in China’s rice paddies could cut fertilizer use

Texas A&M researchers expose hidden risks of firefighter gear in an effort to improve safety and performance

Wood burning in homes drives dangerous air pollution in winter

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 23, 2026

ISSCR statement in response to new NIH policy on research using human fetal tissue (Notice NOT-OD-26-028)

Biologists and engineers follow goopy clues to plant-wilting bacteria

What do rats remember? IU research pushes the boundaries on what animal models can tell us about human memory

Frontiers Science House: did you miss it? Fresh stories from Davos – end of week wrap

Watching forests grow from space

New grounded theory reveals why hybrid delivery systems work the way they do

CDI scientist joins NIH group to improve post-stem cell transplant patient evaluation

Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy

Multiple maternal chronic conditions and risk of severe neonatal morbidity and mortality

Interactive virtual assistant for health promotion among older adults with type 2 diabetes

Ion accumulation in liquid–liquid phase separation regulates biomolecule localization

Hemispheric asymmetry in the genetic overlap between schizophrenia and white matter microstructure

Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)

Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer

Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor

Combined aerobic-resistance exercise: Dual efficacy and efficiency for hepatic steatosis

Expert consensus outlines a standardized framework to evaluate clinical large language models

Bioengineered tissue as a revolutionary treatment for secondary lymphedema

Forty years of tracking trees reveals how global change is impacting Amazon and Andean Forest diversity

Breathing disruptions during sleep widespread in newborns with severe spina bifida

[Press-News.org] 'Not just a flavoring:' Menthol and nicotine, combined, desensitize airway receptors